Top Markets
Coin of the day
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Classifica tra le azioni #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Prezzo delle azioni
$0.6
Ultima sincronizzazione: 2024-08-14
Capitalizzazione di mercato
$2.09M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
SG
Scambia ASLAN Pharmaceuticals Limited (ASLN)

Categoria

Utile per ASLAN Pharmaceuticals Limited (ASLN)
Utile nel Mar 2024 TTM: $-34.90M
Secondo gli ultimi rapporti finanziari di ASLAN Pharmaceuticals Limited, gli utili attuali della società sono $-34.90M. Nel 2022, la società ha registrato un utile di $-51.28M, una diminuzione rispetto a agli utili del 2021, che erano di $-31.59M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di ASLAN Pharmaceuticals Limited dal 2014 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $-34.90M -20.84%
2023 $-44.09M -14.03%
2022 $-51.28M 62.34%
2021 $-31.59M 86.14%
2020 $-16.97M -63.63%
2019 $-46.66M 10.64%
2018 $-42.17M 3.58%
2017 $-40.71M 352.17%
2016 $-9.00M -32.43%
2015 $-13.33M 80.95%
2014 $-7.36M 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$5.27B -15,214.03%
US
$1.95B -5,689.14%
NL
- -
CH
- -
KR
$3.01B -8,712.20%
BE